402 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Kelsen
    Kelsen
  4. Seidman
    Seidman
  5. Motzer
    Motzer
  6. Saltz
    Saltz
  7. Aghajanian
    Aghajanian
  8. Spriggs
    Spriggs
  9. Kemeny
    Kemeny
  10. Kris
    Kris

Groups

  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)
  8. Epidemiology and Biostatistics (49)
  9. Center for Pancreatic Cancer Research (44)
  10. Hematologic Malignancies, Division of (44)
  1. "drug administration schedule"
Formats
  1. Journal Article (392)
  2. Conference Paper (10)
Groups
  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)

More Groups

People
  1. Clifford Hudis (32)
  2. Larry Norton (30)
  3. Andrew Seidman (25)
  4. David Kelsen (25)
  5. Nancy Kemeny (24)
  6. Robert Motzer (24)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (1)
  6. 2017 (7)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Cancer (34)
  3. Clinical Cancer Research (23)
  4. Seminars in Oncology (18)
  5. Gynecologic Oncology (16)
  6. JNCI: Journal of the National Cancer Institute (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (62)
  3. Wiley Blackwell (39)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (27)
  6. Springer (26)

More Publishers

Results (402)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of the addition of cetuximab to paclitaxel, cisplatin, and radiation therapy for patients with esophageal cancer: The NRG Oncology RTOG 0436 phase 3 randomized clinical trial
    Journal Article

    Suntharalingam, M.; Winter, K.; Ilson, D.; Dicker, A. P.; Kachnic, L.; Konski, A.; Chakravarthy, A. B.; Anker, C. J.; Thakrar, H.; Horiba, N.; more...
    JAMA Oncology (2017)

    Fulltext@MSK | Save
  • Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    Journal Article

    Kim, S. B.; Dent, R.; Im, S. A.; EspieĢ, M.; Blau, S.; Tan, A. R.; Isakoff, S. J.; Oliveira, M.; Saura, C.; Wongchenko, M. J.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save
  • Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma
    Journal Article

    Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Zhang, Y.; Chlosta, S.; Shipp, M. A.; Armand, P.
    Blood (2017)

    Fulltext@MSK | Save
  • Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
    Journal Article

    Noy, A.; de Vos, S.; Thieblemont, C.; Martin, P.; Flowers, C. R.; Morschhauser, F.; Collins, G. P.; Ma, S.; Coleman, M.; Peles, S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Extending aromatase-inhibitor adjuvant therapy to 10 years
    Journal Article

    Goss, P. E.; Ingle, J. N.; Pritchard, K. I.; Robert, N. J.; Muss, H.; Gralow, J.; Gelmon, K.; Whelan, T.; Strasser-Weippl, K.; Rubin, S.; more...
    New England Journal of Medicine (2016)

    Fulltext@MSK | Save
  • Cardiac outcomes of patients receiving adjuvant weekly paclitaxel and trastuzumab for node-negative, ERBB2-positive breast cancer
    Journal Article

    Dang, C.; Guo, H.; Najita, J.; Yardley, D.; Marcom, K.; Albain, K.; Rugo, H.; Miller, K.; Ellis, M.; Shapira, I.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • Systemic therapy for osteosarcoma and Ewing sarcoma
    Journal Article

    Meyers, P. A.
    American Society of Clinical Oncology Educational Book (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab in patients with BRAF V600 mutant and BRAF wild-type advanced melanoma: A pooled analysis of 4 clinical trials
    Journal Article

    Larkin, J.; Lao, C. D.; Urba, W. J.; McDermott, D. F.; Horak, C.; Jiang, J.; Wolchok, J. D.
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma
    Journal Article

    Korde, N.; Roschewski, M.; Zingone, A.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Mailankody, S.; Wu, P.; more...
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • Beneficial effects of perioperative statins for major pulmonary resection
    Journal Article

    Amar, D.; Park, B.; Zhang, H.; Shi, W.; Fleisher, M.; Thaler, H. T.; Rusch, V. W.
    Journal of Thoracic and Cardiovascular Surgery (2015)

    Fulltext@MSK | Save